Literature DB >> 9554031

An intricate Web: chemokine receptors, HIV-1 and hematopoiesis.

B Lee1, B J Doranz, M Z Ratajczak, R W Doms.   

Abstract

Cellular infection by the human immunodeficiency virus type 1 (HIV-1) requires interaction of the viral envelope protein with CD4 and at least one additional cell surface molecule, termed a "cofactor" or "coreceptor." Recent discoveries have determined that macrophage-tropic strains of HIV-1 which are largely responsible for sexual transmission require the beta-chemokine receptor CCR5 in addition to CD4, while the T cell tropic viruses that emerge later after infection use the alpha-chemokine receptor CXCR4. Thus, both CD4 and the appropriate chemokine receptor must be expressed on the cell surface in order for HIV-1 to enter the cell and establish an infection. The in vivo importance of CCR5 for HIV-1 is demonstrated by the finding that individuals homozygous for a 32 bp deletion (delta 32) in the CCR5 gene that renders them effectively CCR5-negative are highly resistant to virus infection. In this review, the structure-function correlates of the chemokine receptors that serve as major coreceptors for HIV-1 and simian immunodeficiency virus entry will be reviewed. Since certain chemokines have been implicated as stem cell inhibitory factors, the biological consequences of chemokine receptor expression as it relates to HIV-1-associated hematodyspoiesis will also be discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9554031     DOI: 10.1002/stem.160079

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  11 in total

1.  Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.

Authors:  M Majka; T Rozmyslowicz; B Lee; S L Murphy; Z Pietrzkowski; G N Gaulton; L Silberstein; M Z Ratajczak
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein.

Authors:  D Gibellini; M C Re; F Vitone; N Rizzo; C Maldini; M La Placa; G Zauli
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

3.  HIV-1 infection inhibits cytokine production in human thymic macrophages.

Authors:  Tomasz Rozmyslowicz; Samuel L Murphy; Dareus O Conover; Glen N Gaulton
Journal:  Exp Hematol       Date:  2010-09-25       Impact factor: 3.084

4.  A novel approach to quantify G-protein-coupled receptor dimerization equilibrium using bioluminescence resonance energy transfer.

Authors:  Irina Kufareva; Bryan Stephens; C Taylor Gilliland; Beili Wu; Gustavo Fenalti; Damon Hamel; Raymond C Stevens; Ruben Abagyan; Tracy M Handel
Journal:  Methods Mol Biol       Date:  2013

5.  Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection.

Authors:  Stephanie Venzke; Nico Michel; Ina Allespach; Oliver T Fackler; Oliver T Keppler
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

6.  Aggregation-independent modulation of proteoglycan binding by neutralization of C-terminal acidic residues in the chemokine macrophage inflammatory protein 1alpha.

Authors:  K Ottersbach; G J Graham
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

7.  Pathogen recognition in the human female reproductive tract: expression of intracellular cytosolic sensors NOD1, NOD2, RIG-1, and MDA5 and response to HIV-1 and Neisseria gonorrhea.

Authors:  Mimi Ghosh; Zheng Shen; John V Fahey; Sarah G Crist; Mickey Patel; Jennifer M Smith; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2012-09-17       Impact factor: 3.886

8.  Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration.

Authors:  Manik C Ghosh; Gary D Collins; Bolormaa Vandanmagsar; Kalpesh Patel; Margaret Brill; Arnell Carter; Ana Lustig; Kevin G Becker; William W Wood; Chineye D Emeche; Amanda D French; Michael P O'Connell; Mai Xu; Ashani T Weeraratna; Dennis D Taub
Journal:  Blood       Date:  2009-06-11       Impact factor: 22.113

9.  Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.

Authors:  Oliver T Keppler; Frank J Welte; Tuan A Ngo; Peggy S Chin; Kathryn S Patton; Chia-Lin Tsou; Nancy W Abbey; Mark E Sharkey; Robert M Grant; Yun You; John D Scarborough; Wilfried Ellmeier; Dan R Littman; Mario Stevenson; Israel F Charo; Brian G Herndier; Roberto F Speck; Mark A Goldsmith
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

10.  In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4.

Authors:  Edwin A Higuita; Fabián A Jaimes; Maria T Rugeles; Carlos J Montoya
Journal:  AIDS Res Ther       Date:  2013-05-01       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.